Catalyst Wire Dossier Catalyst Wire Dossier

Porfiromycin

porfiromycin · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Porfiromycin, covering 2010-05-21 to 2014-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors [Phase 1]

See pricing